{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:10:51Z","timestamp":1793826651888,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["LKLY25H180011"],"award-info":[{"award-number":["LKLY25H180011"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Research and Development Program of Zhejiang Province","award":["2024C03171"],"award-info":[{"award-number":["2024C03171"]}]},{"name":"the Key Research and Development Project of Lishui","award":["2023zdyf15"],"award-info":[{"award-number":["2023zdyf15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91890-4","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:39:29Z","timestamp":1743017969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effects and mechanisms of Xiaoyao San on nonalcoholic fatty liver disease rat based on transcriptomics and proteomics analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yunxiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Younas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al Mamun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxiao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"91890_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123\u2013133. https:\/\/doi.org\/10.1002\/hep.29466 (2018).","journal-title":"Hepatology"},{"key":"91890_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.971561","volume":"13","author":"M Shao","year":"2022","unstructured":"Shao, M. et al. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Front. Pharmacol. 13, 971561. https:\/\/doi.org\/10.3389\/fphar.2022.971561 (2022).","journal-title":"Front. Pharmacol."},{"key":"91890_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3760\/cma.j.cn501113-20200708-00382","volume":"29","author":"L Wang","year":"2021","unstructured":"Wang, L., Liu, X. E. & Zhuang, H. Research progress of omics biomarkers for nonalcoholic fatty liver disease. Chin. J. Hepatol. 29, 604\u2013608. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20200708-00382 (2021).","journal-title":"Chin. J. Hepatol."},{"key":"91890_CR4","doi-asserted-by":"publisher","first-page":"154320","DOI":"10.1016\/j.metabol.2020.154320","volume":"111S","author":"N Perakakis","year":"2020","unstructured":"Perakakis, N., Stefanakis, K. & Mantzoros, C. S. The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease. Metabolism 111S, 154320. https:\/\/doi.org\/10.1016\/j.metabol.2020.154320 (2020).","journal-title":"Metabolism"},{"key":"91890_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales, C. et al. Network pharmacology: Curing causal mechanisms instead of treating symptoms. Trends Pharmacol. Sci. 43, 136\u2013150. https:\/\/doi.org\/10.1016\/j.tips.2021.11.004 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"91890_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1080\/13880209.2021.1999275","volume":"59","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis. Pharm. Biol. 59, 1594\u20131606. https:\/\/doi.org\/10.1080\/13880209.2021.1999275 (2021).","journal-title":"Pharm. Biol."},{"key":"91890_CR7","doi-asserted-by":"publisher","first-page":"115324","DOI":"10.1016\/j.jep.2022.115324","volume":"294","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Dynamic network biomarker analysis and system pharmacology methods to explore the therapeutic effects and targets of Xiaoyaosan against liver cirrhosis. J. Ethnopharmacol. 294, 115324. https:\/\/doi.org\/10.1016\/j.jep.2022.115324 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"91890_CR8","doi-asserted-by":"publisher","first-page":"114612","DOI":"10.1016\/j.jep.2021.114612","volume":"282","author":"T Hu","year":"2022","unstructured":"Hu, T. et al. Xiaoyao San attenuates hepatic steatosis through estrogen receptor \u03b1 pathway in ovariectomized ApoE-\/- mice. J. Ethnopharmacol. 282, 114612. https:\/\/doi.org\/10.1016\/j.jep.2021.114612 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"91890_CR9","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.18632\/aging.202832","volume":"13","author":"M Chen","year":"2021","unstructured":"Chen, M. et al. Investigating the mechanisms of Modified Xiaoyaosan in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation. Aging 13, 11411\u201311432. https:\/\/doi.org\/10.18632\/aging.202832 (2021).","journal-title":"Aging"},{"key":"91890_CR10","doi-asserted-by":"publisher","first-page":"948128","DOI":"10.3389\/fphar.2022.948128","volume":"13","author":"Z Bai","year":"2022","unstructured":"Bai, Z. et al. Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway. Front. Pharmacol. 13, 948128. https:\/\/doi.org\/10.3389\/fphar.2022.948128 (2022).","journal-title":"Front. Pharmacol."},{"key":"91890_CR11","doi-asserted-by":"publisher","first-page":"110916","DOI":"10.1016\/j.biopha.2020.110916","volume":"132","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts. Biomed. Pharmacother. 132, 110916. https:\/\/doi.org\/10.1016\/j.biopha.2020.110916 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"91890_CR12","doi-asserted-by":"publisher","first-page":"113021","DOI":"10.1016\/j.jep.2020.113021","volume":"264","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGF\u03b2\/Smad and Akt\/FoxO3 signaling pathways based on network pharmacology analysis. J. Ethnopharmacol. 264, 113021. https:\/\/doi.org\/10.1016\/j.jep.2020.113021 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"91890_CR13","doi-asserted-by":"publisher","first-page":"821802","DOI":"10.3389\/fphar.2021.821802","volume":"12","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Efficacy and safety of chinese herbal medicine Xiao Yao San in functional gastrointestinal disorders: A meta-analysis and trial sequential analysis of randomized controlled trials. Front. Pharmacol. 12, 821802. https:\/\/doi.org\/10.3389\/fphar.2021.821802 (2022).","journal-title":"Front. Pharmacol."},{"key":"91890_CR14","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.1039\/d2fo01009g","volume":"13","author":"M Zhong","year":"2022","unstructured":"Zhong, M. et al. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. Food Funct. 13, 7287\u20137301. https:\/\/doi.org\/10.1039\/d2fo01009g (2022).","journal-title":"Food Funct."},{"key":"91890_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.jcmgh.2022.02.015","volume":"13","author":"K Uehara","year":"2022","unstructured":"Uehara, K. et al. Activation of liver mTORC1 protects against NASH via dual regulation of VLDL-TAG secretion and De Novo lipogenesis. Cell Mol. Gastroenterol. Hepatol. 13, 1625\u20131647. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.02.015 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"91890_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/00365521.2022.2139633","volume":"58","author":"Bj\u00f8rn\u00e5","year":"2023","unstructured":"Bj\u00f8rn\u00e5, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study. Scand. J. Gastroenterol. 58, 505\u2013511. https:\/\/doi.org\/10.1080\/00365521.2022.2139633 (2023).","journal-title":"Scand. J. Gastroenterol."},{"key":"91890_CR17","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.3748\/wjg.v25.i34.5120","volume":"25","author":"CX Li","year":"2019","unstructured":"Li, C. X. et al. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1\/AMPK and NF-\u03baB signaling pathways. World J. Gastroenterol. 25, 5120\u20135133. https:\/\/doi.org\/10.3748\/wjg.v25.i34.5120 (2019).","journal-title":"World J. Gastroenterol."},{"key":"91890_CR18","doi-asserted-by":"publisher","first-page":"6610124","DOI":"10.1155\/2021\/6610124","volume":"2021","author":"S Tao","year":"2021","unstructured":"Tao, S., Yang, Y., Li, J., Wang, H. & Ma, Y. Bixin attenuates high-fat diet-caused liver steatosis and inflammatory injury through Nrf2\/PPAR\u03b1 signals. Oxid. Med. Cell Longev. 2021, 6610124. https:\/\/doi.org\/10.1155\/2021\/6610124 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"key":"91890_CR19","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"91890_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbrc.2018.12.149","volume":"510","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway. Biochem. Biophys. Res. Commun. 510, 20\u201326. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.149 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"91890_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-020-0315-7","volume":"17","author":"JV Lazarus","year":"2020","unstructured":"Lazarus, J. V. et al. NAFLD\u2014Sounding the alarm on a silent epidemic. Nat. Rev. Gastroenterol. Hepatol. 17, 377\u2013379. https:\/\/doi.org\/10.1038\/s41575-020-0315-7 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91890_CR22","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1080\/15384101.2020.1829800","volume":"19","author":"S Shen","year":"2020","unstructured":"Shen, S., Wang, K., Zhi, Y., Shen, W. & Huang, L. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS\/TLR4 signaling pathway. Cell Cycle 19, 3042\u20133053. https:\/\/doi.org\/10.1080\/15384101.2020.1829800 (2020).","journal-title":"Cell Cycle"},{"key":"91890_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.21037\/atm.2020.01.31","volume":"8","author":"Q Yao","year":"2020","unstructured":"Yao, Q. et al. Yin Zhi Huang, a traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK\/SREBP-1 and the AMPK\/ACC\/CPT1A pathways. Ann. Transl. Med. 8, 231. https:\/\/doi.org\/10.21037\/atm.2020.01.31 (2020).","journal-title":"Ann. Transl. Med."},{"key":"91890_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/nu12020329","volume":"12","author":"HY Xu","year":"2020","unstructured":"Xu, H. Y. et al. Sesamol alleviates obesity-related hepatic steatosis via activating hepatic PKA pathway. Nutrients 12, 329. https:\/\/doi.org\/10.3390\/nu12020329 (2020).","journal-title":"Nutrients"},{"key":"91890_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/13880209.2023.2188549","volume":"61","author":"J Tian","year":"2023","unstructured":"Tian, J. et al. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK\/SIRT1\/NF-\u03baB pathway in high-fat-diet-fed C57BL\/6 mice. Pharm. Biol. 61, 647\u2013656. https:\/\/doi.org\/10.1080\/13880209.2023.2188549 (2023).","journal-title":"Pharm. Biol."},{"key":"91890_CR26","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41374-018-0074-z","volume":"98","author":"XJ Liu","year":"2018","unstructured":"Liu, X. J. et al. Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water. Lab Invest. 98, 1184\u20131199. https:\/\/doi.org\/10.1038\/s41374-018-0074-z (2018).","journal-title":"Lab Invest."},{"key":"91890_CR27","doi-asserted-by":"publisher","first-page":"854674","DOI":"10.3389\/fphar.2022.854674","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J. & Feng, Q. Pharmacological effects and molecular protective mechanisms of astragalus polysaccharides on nonalcoholic fatty liver disease. Front. Pharmacol. 13, 854674. https:\/\/doi.org\/10.3389\/fphar.2022.854674 (2022).","journal-title":"Front. Pharmacol."},{"key":"91890_CR28","doi-asserted-by":"publisher","first-page":"114999","DOI":"10.1016\/j.jep.2022.114999","volume":"288","author":"N Liu","year":"2022","unstructured":"Liu, N. et al. Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. J. Ethnopharmacol. 288, 114999. https:\/\/doi.org\/10.1016\/j.jep.2022.114999 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"91890_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fphys.2018.01041","volume":"9","author":"W Zhao","year":"2018","unstructured":"Zhao, W., Feng, X., Liu, B., Xian, J. & Zhang, N. Er-miao-fang extracts inhibits adipose lipolysis and reduces hepatic gluconeogenesis via suppression of inflammation. Front. Physiol. 9, 1041. https:\/\/doi.org\/10.3389\/fphys.2018.01041 (2018).","journal-title":"Front. Physiol."},{"key":"91890_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","volume":"49","author":"B Wahlang","year":"2018","unstructured":"Wahlang, B., McClain, C., Barve, S. & Gobejishvili, L. Role of cAMP and phosphodiesterase signaling in liver health and disease. Cell Signal 49, 105\u2013115. https:\/\/doi.org\/10.1016\/j.cellsig.2018.06.005 (2018).","journal-title":"Cell Signal"},{"key":"91890_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12986-019-0400-5","volume":"16","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. Hepatic PKA inhibition accelerates the lipid accumulation in liver. Nutr. Metab. (Lond). 16, 69. https:\/\/doi.org\/10.1186\/s12986-019-0400-5 (2019).","journal-title":"Nutr. Metab. (Lond)."},{"key":"91890_CR32","doi-asserted-by":"publisher","first-page":"e2200496","DOI":"10.1002\/mnfr.202200496","volume":"67","author":"E Hong","year":"2023","unstructured":"Hong, E., Kang, H., Yang, G., Oh, S. & Kim, E. The PKA-SREBP1c pathway plays a key role in the protective effects of lactobacillus johnsonii JNU3402 against diet-induced fatty liver in mice. Mol. Nutr. Food Res. 67, e2200496. https:\/\/doi.org\/10.1002\/mnfr.202200496 (2023).","journal-title":"Mol. Nutr. Food Res."},{"key":"91890_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/biof.1307","volume":"43","author":"JM Zingg","year":"2017","unstructured":"Zingg, J. M. et al. Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36\/FAT scavenger receptor\/fatty acids transporter gene expression. Biofactors 43, 42\u201353. https:\/\/doi.org\/10.1002\/biof.1307 (2017).","journal-title":"Biofactors"},{"key":"91890_CR34","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1111\/j.1476-5381.2011.01727.x","volume":"165","author":"XH Kou","year":"2012","unstructured":"Kou, X. H. et al. Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPAR\u03b1 in rats fed a high-fat diet. Br. J. Pharmacol. 165, 2692\u20132706. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01727.x (2012).","journal-title":"Br. J. Pharmacol."},{"key":"91890_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jep.2018.12.034","volume":"232","author":"L Ren","year":"2019","unstructured":"Ren, L. et al. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. J. Ethnopharmacol. 232, 176\u2013187. https:\/\/doi.org\/10.1016\/j.jep.2018.12.034 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"91890_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/jmf.2021.K.0170","volume":"25","author":"K Boonloh","year":"2022","unstructured":"Boonloh, K., Thanaruksa, R., Proongkhong, T., Thawornchinsombut, S. & Pannangpetch, P. Nil-surin rice bran hydrolysates improve lipid metabolism and hepatic steatosis by regulating secretion of adipokines and expression of lipid-metabolism genes. J. Med. Food 25, 597\u2013606. https:\/\/doi.org\/10.1089\/jmf.2021.K.0170 (2022).","journal-title":"J. Med. Food"},{"key":"91890_CR37","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","volume":"11","author":"M Cariello","year":"2021","unstructured":"Cariello, M., Piccinin, E. & Moschetta, A. Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH. Cell Mol. Gastroenterol. Hepatol. 11, 1519\u20131539. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.01.012 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"91890_CR38","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","volume":"70","author":"N Sun","year":"2021","unstructured":"Sun, N. et al. Hepatic Kr\u00fcppel-like factor 16 (KLF16) targets PPAR\u03b1 to improve steatohepatitis and insulin resistance. Gut 70, 2183\u20132195. https:\/\/doi.org\/10.1136\/gutjnl-2020-321774 (2021).","journal-title":"Gut"},{"key":"91890_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep4.1474","volume":"4","author":"A Sandoval-Rodriguez","year":"2020","unstructured":"Sandoval-Rodriguez, A. et al. Pirfenidone is an agonistic ligand for PPAR\u03b1 and improves NASH by activation of SIRT1\/LKB1\/pAMPK. Hepatol. Commun. 4, 434\u2013449. https:\/\/doi.org\/10.1002\/hep4.1474 (2020).","journal-title":"Hepatol. Commun."},{"key":"91890_CR40","doi-asserted-by":"publisher","first-page":"110076","DOI":"10.1016\/j.biopha.2020.110076","volume":"126","author":"CH Zhang","year":"2020","unstructured":"Zhang, C. H. et al. Gegen Qinlian Decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways. Biomed. Pharmacother. 126, 110076. https:\/\/doi.org\/10.1016\/j.biopha.2020.110076 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"91890_CR41","doi-asserted-by":"publisher","first-page":"107173","DOI":"10.1016\/j.intimp.2020.107173","volume":"91","author":"X Gong","year":"2021","unstructured":"Gong, X., Li, T., Wan, R. & Sha, L. Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses. Int. Immunopharmacol. 91, 107173. https:\/\/doi.org\/10.1016\/j.intimp.2020.107173 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"91890_CR42","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/ijmm.2019.4059","volume":"43","author":"W Zhang","year":"2019","unstructured":"Zhang, W., Sun, Y., Liu, W., Dong, J. & Chen, J. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPAR\u03b1\/FoxO1 signaling pathway. Int. J. Mol. Med. 43, 1271\u20131280. https:\/\/doi.org\/10.3892\/ijmm.2019.4059 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"91890_CR43","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.2337\/db18-0674","volume":"67","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. Novel mechanism of Foxo1 phosphorylation in glucagon signaling in control of glucose homeostasis. Diabetes 67, 2167\u20132182. https:\/\/doi.org\/10.2337\/db18-0674 (2018).","journal-title":"Diabetes"},{"key":"91890_CR44","doi-asserted-by":"publisher","first-page":"14681","DOI":"10.1074\/jbc.M110.201061","volume":"286","author":"R Tao","year":"2011","unstructured":"Tao, R. et al. Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. J. Biol. Chem. 286, 14681\u201314690. https:\/\/doi.org\/10.1074\/jbc.M110.201061 (2011).","journal-title":"J. Biol. Chem."},{"key":"91890_CR45","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1159\/000492518","volume":"48","author":"S Dumeus","year":"2018","unstructured":"Dumeus, S. et al. Bioactive peptide improves diet-induced hepatic fat deposition and hepatocyte proinflammatory response in SAMP8 ageing mice. Cell. Physiol. Biochem. 48, 1942\u20131952. https:\/\/doi.org\/10.1159\/000492518 (2018).","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"91890_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00210-022-02234-2","volume":"395","author":"U Sabir","year":"2022","unstructured":"Sabir, U., Irfan, H. M., Alamgeer, I. U., Niazi, Z. R. & Asjad, H. M. M. Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways. Naunyn-Schmiedebergs Arch. Pharmacol. 395(7), 741\u2013755. https:\/\/doi.org\/10.1007\/s00210-022-02234-2 (2022).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"91890_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.arcmed.2017.11.016","volume":"48","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Regulation of SIRT3\/FOXO1 signaling pathway in rats with non-alcoholic steatohepatitis by salvianolic acid B. Arch. Med. Res. 48, 506\u2013512. https:\/\/doi.org\/10.1016\/j.arcmed.2017.11.016 (2017).","journal-title":"Arch. Med. Res."},{"key":"91890_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphys.2020.001772020;11:177","volume":"11","author":"HR Ding","year":"2020","unstructured":"Ding, H. R. et al. Protective properties of FOXO1 inhibition in a murine model of non-alcoholic fatty liver disease are associated with attenuation of ER stress and necroptosis. Front. Physiol. 11, 177. https:\/\/doi.org\/10.3389\/fphys.2020.001772020;11:177 (2020).","journal-title":"Front. Physiol."},{"key":"91890_CR49","doi-asserted-by":"publisher","first-page":"e0243938","DOI":"10.1371\/journal.pone.0243938","volume":"16","author":"N Zhao","year":"2021","unstructured":"Zhao, N. et al. Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes. PloS one 16, e0243938. https:\/\/doi.org\/10.1371\/journal.pone.0243938 (2021).","journal-title":"PloS one"},{"key":"91890_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcmgh.2023.08.013","volume":"17","author":"Q Pan","year":"2024","unstructured":"Pan, Q. et al. Hepatocyte FoxO1 deficiency protects from liver fibrosis via reducing inflammation and TGF-\u03b21-mediated HSC activation. Cell. Mol. Gastroenterol. Hepatol. 17, 41\u201358. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.08.013 (2024).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"91890_CR51","doi-asserted-by":"publisher","first-page":"17425","DOI":"10.1038\/s41598-023-44590-w","volume":"13","author":"H Zou","year":"2023","unstructured":"Zou, H. et al. Hippophae rhamnoides reverses decreased CYP2D6 expression in rats with BCG-induced liver injury. Sci. Rep. 13, 17425. https:\/\/doi.org\/10.1038\/s41598-023-44590-w (2023).","journal-title":"Sci. Rep."},{"key":"91890_CR52","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.2337\/db15-0242","volume":"64","author":"B Ke","year":"2015","unstructured":"Ke, B. et al. Inactivation of NF-\u03baB p65 (RelA) in liver improves insulin sensitivity and inhibits cAMP\/PKA pathway. Diabetes 64, 3355\u20133362. https:\/\/doi.org\/10.2337\/db15-0242 (2015).","journal-title":"Diabetes"},{"key":"91890_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10787-023-01147-7","volume":"31","author":"MA Didamoony","year":"2023","unstructured":"Didamoony, M. A., Atwa, A. M. & Ahmed, L. A. A novel mechanistic approach for the anti-fibrotic potential of rupatadine in rat liver via amendment of PAF\/NF-\u0138B p65\/TGF-\u03b21 and hedgehog\/HIF-1\u03b1\/VEGF trajectories. Inflammopharmacology 31, 845\u2013858. https:\/\/doi.org\/10.1007\/s10787-023-01147-7 (2023).","journal-title":"Inflammopharmacology"},{"key":"91890_CR54","doi-asserted-by":"publisher","first-page":"107703","DOI":"10.1007\/s11356-023-29702-3","volume":"30","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. Filamin A facilitates NLRP3 inflammasome activation during arsenic-induced nonalcoholic steatohepatitis. Environ. Sci. Pollut. Res. Int. 30, 107703\u2013107715. https:\/\/doi.org\/10.1007\/s11356-023-29702-3 (2023).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"91890_CR55","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/nu14091699","volume":"14","author":"W Zhao","year":"2022","unstructured":"Zhao, W. et al. Myristica fragrans extract regulates gut microbes and metabolites to attenuate hepatic inflammation and lipid metabolism disorders via the AhR-FAS and NF-\u03baB signaling pathways in mice with non-alcoholic fatty liver disease. Nutrients 14, 1699. https:\/\/doi.org\/10.3390\/nu14091699 (2022).","journal-title":"Nutrients"},{"key":"91890_CR56","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1021\/acs.jafc.3c02337","volume":"71","author":"F Guo","year":"2023","unstructured":"Guo, F. et al. Green pea (Pisum sativum\u00a0L.) Hull polyphenol extract alleviates NAFLD through VB6\/TLR4\/NF-\u03baB and PPAR pathways. J. Agric. Food Chem. 71, 16067\u201316078. https:\/\/doi.org\/10.1021\/acs.jafc.3c02337 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"91890_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/nu14010042","volume":"14","author":"Y Aoyama","year":"2021","unstructured":"Aoyama, Y. et al. Lactoferrin prevents hepatic injury and fibrosis via the inhibition of NF-\u03baB signaling in a rat non-alcoholic steatohepatitis model. Nutrients 14, 42. https:\/\/doi.org\/10.3390\/nu14010042 (2021).","journal-title":"Nutrients"},{"key":"91890_CR58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jphs.2021.05.006","volume":"147","author":"Z Wei","year":"2021","unstructured":"Wei, Z. et al. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK\/NF-\u03baB signaling pathways. J. Pharmacol. Sci. 147, 72\u201380. https:\/\/doi.org\/10.1016\/j.jphs.2021.05.006 (2021).","journal-title":"J. Pharmacol. Sci."},{"key":"91890_CR59","doi-asserted-by":"publisher","first-page":"119963","DOI":"10.1016\/j.lfs.2021.119963","volume":"285","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2\/NF\u03baB signaling pathway. Life Sci. 285, 119963. https:\/\/doi.org\/10.1016\/j.lfs.2021.119963 (2021).","journal-title":"Life Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91890-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:39:37Z","timestamp":1743017977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91890-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91890"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91890-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10478"}}